This report describes the results of bone marrow leukocyte immunophenotypic studies, DNA index measurement, and chromosome analysis in a newborn with Down syndrome and transient myeloproliferative disorder. The infant’s initial leukocytosis with immature cells in the periph-eral blood and thrombocytopenia resolved without treatment by 6 months of age, and he was well at 2 years of age. The lack of specific reactivity between the patient’s morphologically immature cells and multiple monoclonal antibodies directed against lymphoid and myeloid leukemia cells may be characteristic of this disorder. Other cases should be examined for immunophenotype to correlate the results with chromosomal analysis and to provide a basis for comparison in those...
Introduction: Langdon Down syndrome (Trisomy 21) is the most common genetic syndrome compatible with...
Down syndrome (DS) or trisomy 21 is the most prevalent chromosomopathy. Interesting associations hav...
Neonatal leukaemia is defined as occurring within the first 28 days of life and most, if not all, ca...
Down syndrome (DS) or trisomy 21 is the most prevalent chromosomopathy. Interesting associations hav...
We report peripheral blood film and cytogenetic results of a five day old neonate who presented with...
A unique transient leukemia (TL) has been described in newborns with Down syn-drome (DS; or trisomy ...
Neonates with Down's syndrome may develop a transient myeloproliferative disorder (TMPD) which on pr...
BACKGROUND: An increased frequency of acute myelogenous leukemia is a well-known feature in children...
The incidence of leukemia in Down syndrome is 10 to 20 folds higher than that in the general populat...
Observations were made of the blood marrow. Initially it appeared the patient and bone marrow of a m...
Children with Down syndrome (DS) have an increased risk of Acute Myeloid Leukaemia (ML-DS), particul...
Transient abnormal myelopoiesis (TAM) with Down Syndrome is characterized by increased blast cells a...
Constitutional trisomy 21 inherent to Down syndrome (DS) is associated with several hematological di...
WOS: 000219054200011Down Syndrome (DS) is an important genetic disease resulting from partial or tot...
Children with Down syndrome have an increased risk for developing both acute myeloid as well as lymp...
Introduction: Langdon Down syndrome (Trisomy 21) is the most common genetic syndrome compatible with...
Down syndrome (DS) or trisomy 21 is the most prevalent chromosomopathy. Interesting associations hav...
Neonatal leukaemia is defined as occurring within the first 28 days of life and most, if not all, ca...
Down syndrome (DS) or trisomy 21 is the most prevalent chromosomopathy. Interesting associations hav...
We report peripheral blood film and cytogenetic results of a five day old neonate who presented with...
A unique transient leukemia (TL) has been described in newborns with Down syn-drome (DS; or trisomy ...
Neonates with Down's syndrome may develop a transient myeloproliferative disorder (TMPD) which on pr...
BACKGROUND: An increased frequency of acute myelogenous leukemia is a well-known feature in children...
The incidence of leukemia in Down syndrome is 10 to 20 folds higher than that in the general populat...
Observations were made of the blood marrow. Initially it appeared the patient and bone marrow of a m...
Children with Down syndrome (DS) have an increased risk of Acute Myeloid Leukaemia (ML-DS), particul...
Transient abnormal myelopoiesis (TAM) with Down Syndrome is characterized by increased blast cells a...
Constitutional trisomy 21 inherent to Down syndrome (DS) is associated with several hematological di...
WOS: 000219054200011Down Syndrome (DS) is an important genetic disease resulting from partial or tot...
Children with Down syndrome have an increased risk for developing both acute myeloid as well as lymp...
Introduction: Langdon Down syndrome (Trisomy 21) is the most common genetic syndrome compatible with...
Down syndrome (DS) or trisomy 21 is the most prevalent chromosomopathy. Interesting associations hav...
Neonatal leukaemia is defined as occurring within the first 28 days of life and most, if not all, ca...